🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Randomized, controlled, double-blind, single-center, double-blind clinical ...
Status
Completed
Location
Catholic University of Murcia
Start Date
2023-12-04
Trial ID
NCT06180512
Treatments Being Tested
This study will address the question of whether targeting CMV antigens with...
Status
Recruiting
Location
Children's Hospital Colorado
Start Date
2024-07-18
Trial ID
NCT05096481
Treatments Being Tested
Study Hypothesis: Preterm infants administered weekly Darbe during the neon...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2017-09-20
Trial ID
NCT03169881
Treatments Being Tested
The purpose of this study is to examine how effective rituximab or tocilizu...
Status
Active Not Recruiting
Location
Johns Hopkins
Start Date
2020-09-25
Trial ID
NCT04375228
Treatments Being Tested
In this phase II trial, the investigators overarching goal is to demonstrat...
Status
Recruiting
Location
University of Washington
Start Date
2022-11-27
Trial ID
NCT05340465
Treatments Being Tested
This is a phase II, observer-blind, multiple-centre, randomized, placebo-co...
Status
Terminated
Location
Changhua Christian Hospital
Start Date
2021-01-30
Trial ID
NCT04773067
Open label multicentric randomized phase II trial, using high throughput ge...
Status
Completed
Location
Centre Hospitalier Henri Duffau
Start Date
2014-04-23
Trial ID
NCT02117167
This research study is testing whether a weekly medication called tirzepati...
Status
Recruiting
Location
Institut de Recherches Cliniques de Montréal
Start Date
2026-05-19
Trial ID
NCT07284511
To study the effects of Erigeron Injection on human serum VEGF, MMP-9 and E...
Status
Unknown
Location
Multiple Locations
Start Date
2013-08
Trial ID
NCT01926834
Treatments Being Tested
This study is conducted in 3 stages. Stage 1 is an open-label, dose-escalat...
Status
Completed
Location
Multiple Locations
Start Date
2011-09-01
Trial ID
NCT01397409
Treatments Being Tested